Ian D. Meng

4.3k total citations · 1 hit paper
44 papers, 3.5k citations indexed

About

Ian D. Meng is a scholar working on Physiology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Ian D. Meng has authored 44 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 14 papers in Cellular and Molecular Neuroscience and 14 papers in Sensory Systems. Recurrent topics in Ian D. Meng's work include Pain Mechanisms and Treatments (23 papers), Ocular Surface and Contact Lens (13 papers) and Cannabis and Cannabinoid Research (10 papers). Ian D. Meng is often cited by papers focused on Pain Mechanisms and Treatments (23 papers), Ocular Surface and Contact Lens (13 papers) and Cannabis and Cannabinoid Research (10 papers). Ian D. Meng collaborates with scholars based in United States, Japan and Canada. Ian D. Meng's co-authors include Huai-hu Chuang, Sven‐Eric Jordt, David D. McKemy, Diana M. Bautista, Edward D. Högestätt, David Julius, Peter M. Zygmunt, Barton H. Manning, Masayuki Kurose and William J. Martin and has published in prestigious journals such as Nature, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Ian D. Meng

43 papers receiving 3.4k citations

Hit Papers

Mustard oils and cannabinoids excite sensory nerve fibres... 2004 2026 2011 2018 2004 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian D. Meng United States 25 1.6k 1.3k 1.2k 516 505 44 3.5k
Amol Patwardhan United States 31 883 0.6× 1.3k 1.0× 973 0.8× 585 1.1× 280 0.6× 65 2.9k
Christopher M. Flores United States 35 1.6k 1.0× 1.6k 1.2× 1.6k 1.3× 739 1.4× 301 0.6× 82 4.3k
Sharon Bingham United Kingdom 25 1.2k 0.8× 1.5k 1.2× 905 0.7× 316 0.6× 224 0.4× 36 3.2k
Radhouane Dallel France 36 457 0.3× 2.7k 2.0× 1.5k 1.2× 476 0.9× 709 1.4× 116 4.1k
Alison J. Reeve United Kingdom 20 3.7k 2.4× 2.2k 1.7× 2.3k 1.8× 389 0.8× 227 0.4× 24 6.3k
Kate Skinner United States 15 2.0k 1.3× 1.7k 1.3× 1.2k 1.0× 197 0.4× 242 0.5× 19 3.5k
Jonathan P. Hatcher United Kingdom 12 1.1k 0.7× 1.2k 0.9× 811 0.7× 165 0.3× 156 0.3× 19 2.5k
Daniel N. Cortright United States 23 1.7k 1.1× 1.5k 1.1× 945 0.8× 427 0.8× 103 0.2× 33 3.3k
Vito de Novellis Italy 46 520 0.3× 2.4k 1.8× 2.1k 1.7× 1.7k 3.4× 185 0.4× 127 5.3k
Jennifer M.A. Laird Spain 36 443 0.3× 3.2k 2.4× 2.0k 1.6× 844 1.6× 280 0.6× 68 4.9k

Countries citing papers authored by Ian D. Meng

Since Specialization
Citations

This map shows the geographic impact of Ian D. Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian D. Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian D. Meng more than expected).

Fields of papers citing papers by Ian D. Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian D. Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian D. Meng. The network helps show where Ian D. Meng may publish in the future.

Co-authorship network of co-authors of Ian D. Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Ian D. Meng. A scholar is included among the top collaborators of Ian D. Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian D. Meng. Ian D. Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pattar, Guruprasad R., David Wirta, Gary Jerkins, et al.. (2025). Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease. Ophthalmology.
2.
Meng, Ian D., et al.. (2022). Evidence for a phenotypic switch in corneal afferents after lacrimal gland excision. Experimental Eye Research. 218. 109005–109005. 7 indexed citations
3.
Johansen, Joshua P., et al.. (2015). Alterations in the rostral ventromedial medulla after the selective ablation of μ-opioid receptor expressing neurons. Pain. 157(1). 166–173. 18 indexed citations
4.
Meng, Ian D., et al.. (2013). Lacrimal gland removal increases primary afferent driven spontaneous blinking and produces ocular hyperalgesia in the rat. Investigative Ophthalmology & Visual Science. 54(15). 906–906. 1 indexed citations
5.
Meng, Ian D. & Masayuki Kurose. (2013). The role of corneal afferent neurons in regulating tears under normal and dry eye conditions. Experimental Eye Research. 117. 79–87. 70 indexed citations
6.
Winterson, Barbara J., et al.. (2011). Chronic Morphine Increases Fos‐Positive Neurons After Concurrent Cornea and Tail Stimulation. Headache The Journal of Head and Face Pain. 52(2). 262–273. 7 indexed citations
8.
Okada‐Ogawa, Akiko, Masayuki Kurose, & Ian D. Meng. (2010). Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist. Brain Research. 1359. 81–89. 4 indexed citations
9.
Felice, Milena De, Michael H. Ossipov, Gregory Dussor, et al.. (2010). Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain. 133(8). 2475–2488. 103 indexed citations
10.
Okada‐Ogawa, Akiko, Frank Porreca, & Ian D. Meng. (2009). Sustained Morphine-Induced Sensitization and Loss of Diffuse Noxious Inhibitory Controls in Dura-Sensitive Medullary Dorsal Horn Neurons. Journal of Neuroscience. 29(50). 15828–15835. 71 indexed citations
11.
Meng, Ian D. & Ling Cao. (2007). From Migraine To Chronic Daily Headache: The Biological Basis of Headache Transformation. Headache The Journal of Head and Face Pain. 47(8). 1251–1258. 37 indexed citations
12.
Ogawa, Akiko & Ian D. Meng. (2006). The cannabinoid receptor agonist, WIN 55,212-2, inhibits cool-specific lamina I medullary dorsal horn neurons. Neuroscience. 143(1). 265–272. 3 indexed citations
13.
Meng, Ian D., et al.. (2004). Kappa Opioids Inhibit Physiologically Identified Medullary Pain Modulating Neurons and Reduce Morphine Antinociception. Journal of Neurophysiology. 93(3). 1138–1144. 36 indexed citations
14.
Meng, Ian D. & Joshua P. Johansen. (2004). Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist. Neuroscience. 124(3). 685–693. 58 indexed citations
16.
Manning, Barton H., William J. Martin, & Ian D. Meng. (2003). The rodent amygdala contributes to the production of cannabinoid-induced antinociception. Neuroscience. 120(4). 1157–1170. 73 indexed citations
18.
Meng, Ian D., James W. Hu, & David A. Bereiter. (2000). Parabrachial area and nucleus raphe magnus inhibition of corneal units in rostral and caudal portions of trigeminal subnucleus caudalis in the rat. Pain. 87(3). 241–251. 29 indexed citations
20.
Meng, Ian D. & Robert C. Drugan. (1993). Sex differences in open-field behavior in response to the β-carboline FG 7142 in rats. Physiology & Behavior. 54(4). 701–705. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026